cisapride has been researched along with Anorexia Nervosa in 6 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Anorexia Nervosa: An eating disorder that is characterized by the lack or loss of APPETITE, known as ANOREXIA. Other features include excess fear of becoming OVERWEIGHT; BODY IMAGE disturbance; significant WEIGHT LOSS; refusal to maintain minimal normal weight; and AMENORRHEA. This disorder occurs most frequently in adolescent females. (APA, Thesaurus of Psychological Index Terms, 1994)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the efficacy of cisapride, 10 mg three times daily, in improving gastric emptying, reducing distress during meals, and facilitating weight gain in anorexia nervosa, we conducted an 8-week, randomized, double-blind, placebo-controlled trial on 29 inpatients." | 9.08 | A controlled trial of cisapride in anorexia nervosa. ( Binns, DS; Lichtenstein, M; Miller, G; Szmukler, GI; Young, GP, 1995) |
| "In a double-blind trial, 12 out-patients with primary anorexia nervosa received, for six weeks, either 10 mg cisapride or placebo, three times a day." | 9.07 | Gastric emptying, body weight and symptoms in primary anorexia nervosa. Long-term effects of cisapride. ( Abatzi-Wenzel, TA; Bergmann, H; Gaupmann, G; Schneider, C; Stacher, G; Wiesnagrotzki, S, 1993) |
| "To determine the efficacy of cisapride, 10 mg three times daily, in improving gastric emptying, reducing distress during meals, and facilitating weight gain in anorexia nervosa, we conducted an 8-week, randomized, double-blind, placebo-controlled trial on 29 inpatients." | 5.08 | A controlled trial of cisapride in anorexia nervosa. ( Binns, DS; Lichtenstein, M; Miller, G; Szmukler, GI; Young, GP, 1995) |
| "In a double-blind trial, 12 out-patients with primary anorexia nervosa received, for six weeks, either 10 mg cisapride or placebo, three times a day." | 5.07 | Gastric emptying, body weight and symptoms in primary anorexia nervosa. Long-term effects of cisapride. ( Abatzi-Wenzel, TA; Bergmann, H; Gaupmann, G; Schneider, C; Stacher, G; Wiesnagrotzki, S, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Szmukler, GI | 1 |
| Young, GP | 1 |
| Miller, G | 1 |
| Lichtenstein, M | 1 |
| Binns, DS | 1 |
| Lee, S | 1 |
| Stacher, G | 2 |
| Abatzi-Wenzel, TA | 1 |
| Wiesnagrotzki, S | 2 |
| Bergmann, H | 2 |
| Schneider, C | 2 |
| Gaupmann, G | 2 |
| García Aroca, J | 1 |
| Alonso Calderón, JL | 1 |
| García Redondo, C | 1 |
| Rollán Villamarín, V | 1 |
| Ricci, DA | 1 |
| McCallum, RW | 1 |
| Kiss, A | 1 |
| Mittelbach, G | 1 |
| Höbart, J | 1 |
1 review available for cisapride and Anorexia Nervosa
| Article | Year |
|---|---|
Diagnosis and treatment of delayed gastric emptying.
Topics: Anemia, Pernicious; Anorexia Nervosa; Cisapride; Connective Tissue Diseases; Diabetes Complications; | 1988 |
3 trials available for cisapride and Anorexia Nervosa
| Article | Year |
|---|---|
A controlled trial of cisapride in anorexia nervosa.
Topics: Adolescent; Adult; Anorexia Nervosa; Cisapride; Dose-Response Relationship, Drug; Double-Blind Metho | 1995 |
Gastric emptying, body weight and symptoms in primary anorexia nervosa. Long-term effects of cisapride.
Topics: Adult; Anorexia Nervosa; Body Weight; Cisapride; Dose-Response Relationship, Drug; Double-Blind Meth | 1993 |
Intravenous cisapride accelerates delayed gastric emptying and increases antral contraction amplitude in patients with primary anorexia nervosa.
Topics: Adolescent; Adult; Anorexia Nervosa; Cisapride; Drug Evaluation; Female; Gastric Emptying; Humans; I | 1987 |
2 other studies available for cisapride and Anorexia Nervosa
| Article | Year |
|---|---|
Gastric emptying and bloating in anorexia nervosa.
Topics: Adult; Anorexia Nervosa; Body Image; Body Weight; Cisapride; Dyspepsia; Female; Gastric Emptying; Ho | 1993 |
[Anorexia nervosa or somatic disease].
Topics: Adolescent; Anorexia Nervosa; Cisapride; Erythromycin; Female; Gastroesophageal Reflux; Gastrointest | 2001 |